Year: 2018. The FDA Adverse Event Reporting System (FAERS) registered 23 drug adverse reports.
|
| Month |
Report ID(s) |
Medicinal Product(s) |
Generic Name(s) |
Brand Name(s) |
Product NDC(s) |
Package NDC(s) |
| 12 |
|
- SYSTANE (HYPROMELLOSE 2910 (4000 MPA.S))
|
|
|
|
|
| 11 |
|
- GENTEAL MILD
- GENTEAL MILD TO MODERATE
- GENTEAL PF
- GENTEAL PF LUBRICANT EYE DROPS
- SYSTANE (HYPROMELLOSE 2910 (4000 MPA.S))
|
|
|
|
|
| 10 |
|
- GENTEAL PF LUBRICANT EYE DROPS
|
|
|
|
|
| 09 |
|
- GENTEAL MILD
- SYSTANE (HYPROMELLOSE 2910 (4000 MPA.S))
|
|
|
|
|
| 08 |
|
- SYSTANE (HYPROMELLOSE 2910 (4000 MPA.S))
|
|
|
|
|
| 07 |
|
|
|
|
|
|
| 06 |
|
- SYSTANE (HYPROMELLOSE 2910 (4000 MPA.S))
|
|
|
|
|
| 01 |
|
- SYSTANE (HYPROMELLOSE 2910 (4000 MPA.S))
|
|
|
|
|
Year: 2017. The FDA Adverse Event Reporting System (FAERS) registered 14 drug adverse reports.
|
| Month |
Report ID(s) |
Medicinal Product(s) |
Generic Name(s) |
Brand Name(s) |
Product NDC(s) |
Package NDC(s) |
| 12 |
|
- SYSTANE (HYPROMELLOSE 2910 (4000 MPA.S))
|
- POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL
|
|
|
|
| 11 |
|
- SYSTANE (HYPROMELLOSE 2910 (4000 MPA.S))
|
|
|
|
|
| 09 |
|
- SYSTANE (HYPROMELLOSE 2910 (4000 MPA.S))
|
|
|
|
|
| 08 |
|
- SYSTANE (HYPROMELLOSE 2910 (4000 MPA.S))
|
|
|
|
|
| 06 |
|
- SYSTANE (HYPROMELLOSE 2910 (4000 MPA.S))
|
|
|
|
|
| 04 |
|
|
|
|
|
|
| 02 |
|
- SYSTANE (HYPROMELLOSE 2910 (4000 MPA.S))
|
- CELECOXIB
- CYCLOSPORINE
- FENTANYL
- FENTANYL TRANSDERMAL SYSTEM
- FUROSEMIDE
- LEVOFLOXACIN
|
- ABSTRAL
- CELEBREX
- CEQUA
- CYCLOSPORINE
- CYCLOSPORINE MODIFIED
- DIASCREEN 12-PANEL MEDICATED COLLECTION SYSTEM
- DURAGESIC
- DURAGESIC (FENTANYL SYSTEM)
- FENTANYL
- FENTANYL SYSTEM
- FENTANYL TRANSDERMAL SYSTEM
- FENTORA
- FUROSEMIDE
- GENGRAF
- LASIX
- LAZANDA
- LEVAQUIN
- LEVOFLOXACIN
- NEORAL
- RESTASIS
- RESTASIS MULTIDOSE
- SANDIMMUNE
- SUBSYS
- TOXYCOLOGY MEDICATED COLLECTION SYSTEM
|
|
|